CA3283434A1 - Diaminophénothiazine pour le traitement de maladies microvasculaires du cerveau - Google Patents

Diaminophénothiazine pour le traitement de maladies microvasculaires du cerveau

Info

Publication number
CA3283434A1
CA3283434A1 CA3283434A CA3283434A CA3283434A1 CA 3283434 A1 CA3283434 A1 CA 3283434A1 CA 3283434 A CA3283434 A CA 3283434A CA 3283434 A CA3283434 A CA 3283434A CA 3283434 A1 CA3283434 A1 CA 3283434A1
Authority
CA
Canada
Prior art keywords
disease
diaminophenothiazine
treatment
microvascular brain
microvascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3283434A
Other languages
English (en)
Inventor
Claude Michel Wischik
Shailendra Mohan TRIPATHI
Alison Dorothy Murray
Roger Todd Staff
Helen Shiells
Bjoern Olaf SCHELTER
Original Assignee
Taurx Therapeutics Management Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taurx Therapeutics Management Ltd filed Critical Taurx Therapeutics Management Ltd
Publication of CA3283434A1 publication Critical patent/CA3283434A1/fr
Pending legal-status Critical Current

Links

CA3283434A 2023-03-03 2024-02-28 Diaminophénothiazine pour le traitement de maladies microvasculaires du cerveau Pending CA3283434A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN202311014304 2023-03-03

Publications (1)

Publication Number Publication Date
CA3283434A1 true CA3283434A1 (fr) 2024-09-12

Family

ID=

Similar Documents

Publication Publication Date Title
ZA202212876B (en) 4-oxo-3,4-dihydroquinazolinon compounds for the treatment of braf-associated diseases and disorders
CA3256604A1 (fr) Composés hétéroaryles pour le traitement de la douleur
IL321845A (en) 1-Amino-4-phenylphthalazine derivatives are useful for the treatment of neurodegenerative diseases
IL320898A (en) Phthalazine-based modulators for the treatment of diseases
AU2024228957A1 (en) Hydroquinazoline derivatives for the treatment of a disease or disorder
CA3266876A1 (fr) Analogues de rifabutine pour le traitement d'une maladie
EP4069251A4 (fr) Sels et polymorphes de céthromycine pour le traitement de sels et de polymorphes de céthromycine
GB202011522D0 (en) Neuromodulation for the treatment of circulatory system diseases
EP4217355A4 (fr) Agents pour le traitement de maladies par inhibition de foxo1
AU2021343534A9 (en) TREATMENT OF NF-κB-MEDIATED DISEASE
EP4232458A4 (fr) Composés et méthodes pour le traitement de troubles oculaires
CA3283434A1 (fr) Diaminophénothiazine pour le traitement de maladies microvasculaires du cerveau
AU2022242765A1 (en) Combined treatment of brain injury
AU2021903178A0 (en) Treatment of VEGFA-Related Disease
AU2020903576A0 (en) Treatment of VEGFA-Related Disease
HK40119944A (en) Use of niraparib for the treatment of brain cancer
GB201911728D0 (en) Bacterial composistions for the treatment of disease
HK40131570A (zh) 用於治疗疾病的基於酞嗪酮的调节剂
CA3273570A1 (fr) Modulateurs à base de phtalazinone pour le traitement d'une maladie
GB202302480D0 (en) shRNA for the treatment of disease
HK40092097A (en) Cd38 antibodies for the treatment of human diseases
HK40081973A (en) Combination treatment for fumarate-related diseases
HK40128051A (en) Compositions for the treatment of disease
HK40115989A (en) Rifabutin analogs for the treatment of disease
HK40122913A (en) Rifabutin analogs for the treatment of disease